Medications for Psoriasis
by
Michelle Badash, MS The information provided here is meant to give you a general idea of what to expect from each of these medications. Only the most common side effects are included, so ask your healthcare provider if there are any cautions specific to your case. Use each of these medications as recommended by your healthcare provider, or according to the instructions provided. If you have further questions about usage or side effects, contact your healthcare provider. A variety of medications are used to treat psoriasis. Your treatment will be based on the type of psoriasis you have and its severity. Generally, you will start with medications that are topical, and have the fewest side effects, and then gradually move to the next level or type of medication, if needed. Prescription Medications
Topical MedicationsCommon names include:
The following topical prescription medications are generally considered step one therapies and are used as first-line treatment for mild-to-moderate psoriasis. They be used in combination and with other forms of treatment. Corticosteroids Corticosteroids are used for treating inflammation of mild-to-moderate psoriasis. Available in many forms (such as, ointments, creams, sprays, gels, shampoos and foams) and strengths, they are a synthetic version of hormones that occur naturally in the body. The weaker, over-the-counter strengths are usually not effective in treating psoriasis. Unlike systemic steroids, withdrawal (stopping) of topical steroids does not flare psoriasis. Vitamin D analogs Calcipotriene and calcitriol are synthetic forms of vitamin D used for treating mild-to-moderate psoriasis. It is a prescription medication that is available as a cream, ointment, or scalp solution. It can be used in conjunction with other treatments, but should be used in limited amounts to avoid side effects such as local irritation, rash, or worsening of psoriasis. Calcipotriene has recently become available in combination with a topical steroid betamethasone. Anthralin Anthralin can be very effective for treating mild-to-moderate psoriasis, particularly the tough-to-treat thick patches. It is often used in conjunction with ultraviolet light treatments. This treatment has no known long-term side effects, but may irritate skin and stain clothes. Anthralin is rarely used in modern psoriasis treatment regimens. Retinoids Tazarotene is used in treatment of mild to moderate psoriasis to help reduce skin reddening and reduce the size and number of lesions. It may be prescribed alone or in conjunction with topical steroids. It is available as a gel or cream that is applied once a day and is used for skin, scalp, and nail psoriasis
Salicylic Acid This medication is used to soften and remove scale from psoriasis plaques. When scales are removed, other medications may penetrate the skin and promote healing. Salicylic acid is available in many strengths and types of preparations. Milder strengths are available without prescription. Common side effects may include:
Oral Systemic MedicationsMethotrexateThis medication suppresses the immune system. It is very helpful in reducing psoriasis symptoms. It works by interfering with certain types of skin cell growth, thus slowing the process of psoriasis cell reproduction. It is taken on a weekly (NOT daily) basis, in either oral or injectable form Possible side effects include:
CyclosporineCyclosporine works by suppressing certain immune functions and reducing the growth of skin cells. Note: Do not take this medication with grapefruit or grapefruit juice, as it will increase its effect. Possible side effects may include:
Note: These drugs should not be taken:
AcitretinAcitretin is a retinoid which are vitamin A related medications. It is not know how it works. Acitretin is used to control and relieve moderate-to-severe psoriasis. It works by allowing normal growth and development of skin. Possible side effects include:
Contraindications:
ApremilastApremilast is phosphodiesterase 4 (PDE4) enzyme inhibitor that reduces inflammatory action in the cells Possible side effects include:
TofacitinibTofacitinib is a Janus kinase enzyme inhibitor that reducess inflammatory action in the cells Possible side effects include:
Rare complications may include:
Biologic Response ModifiersCommon names include:
These medications are prescribed when conventional medications have failed. They are taken as an IV infusion or as an injection. They work by blocking the action of factors causing the inflammation implicated in the development of psoriasis, including:
These treatments inhibit inflammatory activation and may reduce excessive skin growth. All patients receiving these medications must first undergo a skin test for tuberculosis, a chest x-ray, a complete blood count, as well as blood tests for liver and kidney function. Certain blood tests will continue to be monitored throughout the course of treatment. Possible side effects include:
Serious complications may include:
Contraindications:
Special ConsiderationsWhenever you are taking a prescription medication, take the following precautions:
When to Contact Your DoctorContact your doctor if you have any adverse reactions to new or existing medication treatments, or if you feel that a new medication is not working. Also, call anytime you have questions about using your medication. References:
Psoriasis. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T116742/Psoriasis
. Updated December 4, 2017. Accessed December 22, 2017.
Psoriasis. National Institute of Arthritis and Musculoskeletal and Skin diseases. Available at:
https://www.niams.nih.gov/health-topics/psoriasis. Updated March 3, 2017. Accessed December 22, 2017. Psoriatic disease. National Psoriasis Foundation website. Available at: ...(Click grey area to select URL) Accessed December 22, 2017.
10/2/2009 DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T116742/Psoriasis: FDA approves new drug to treat psoriasis. United States Food and Drug Administration website. Available at: ...(Click grey area to select URL) Published September 25, 2009. Accessed November 24, 2015.
10/15/2010
DynaMed Plus Systematic Literature Surveillance
http://www.dynamed.com/topics/dmp~AN~T116742/Psoriasis
: Menter A, Gordon KB, et al. Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.
J Am Acad Dermatol. 2010;63(3):448-456.
Last reviewed November 2018 by
EBSCO Medical Review Board
Michael Woods MD, FAAP Last Updated: 12/22/2017 |
|
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. |